TRB Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.07M Buy
7,915
+88
+1% +$22.6K 0.29% 54
2026
Q2
$1.97M Sell
7,827
-5,019
-39% -$1.08M 0.26% 54
2026
Q1
$2.79M Buy
+12,846
New +$2.85M 0.4% 48

Other funds holding ABBV

TRB Wealth Management's ABBV Position: Q3 2026 in Review

TRB Wealth Management increased its AbbVie (ABBV) stake by 1.1% in Q3 2026, buying an estimated $22.6K and bringing the position to 7,915 shares worth $2.07M. The position accounts for 0.29% of the portfolio, ranked #54.

TRB Wealth Management first reported a position in ABBV in Q1 2026 and has held it in 3 quarters since. The position peaked at $2.79M in Q1 2026. 4,273 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • TRB Wealth Management held 7,915 shares of AbbVie worth $2.07M as of Q3 2026.
  • TRB Wealth Management bought 88 AbbVie shares in Q3 2026, an estimated $22.6K.
  • AbbVie made up 0.29% of TRB Wealth Management's portfolio in Q3 2026, its #54 holding.
  • TRB Wealth Management first reported a position in AbbVie in Q1 2026 and has held it in 3 quarters since.
  • TRB Wealth Management's AbbVie position peaked at $2.79M in Q1 2026.
  • 4,273 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on TRB Wealth Management's 13F filing for Q3 2026, filed 16 Nov 2026.